Try our beta test site
1 study found for:    16678648 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: ADHD
Interventions: Drug: Mixed salts of a single-entity amphetamine (ADDERALL XR);   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.